ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,248, issued on April 7, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).
"PRMT5 inhibitors" was invented by Michelle Machacek (Belmont, Mass.), Michael D. Altman (Needham, Mass.), Chunghui Huang (Arlington, Mass.), Michael H. Reutershan (Brighton, Mass.), David L. Sloman (Newton, Mass.), Phieng Siliphaivanh (Newton Highlands, Mass.), Sebastian E. Schneider (Cambridge, Mass.), Charles S. Yeung (Dedham, Mass.), David J. Witter (Toronto), Craig R. Gibeau (Northborough, Mass.) and Yingchun Ye (Belmont, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a compound of Formula (I) and the pharmaceutically acceptable ...